| Avalo Therapeutics, Inc. |
Director |
Stock Option (Right to Buy) |
848 |
$12,499 |
$14.74 |
31 Dec 2025 |
Direct |
| Longboard Pharmaceuticals, Inc. |
President and CEO, Director |
Common Stock |
0 |
$0 |
$60.00 |
02 Dec 2024 |
Direct |
| Longboard Pharmaceuticals, Inc. |
President and CEO, Director |
Stock Option (Right to Buy) |
255,377 |
|
|
13 Nov 2024 |
Direct |
| Longboard Pharmaceuticals, Inc. |
President and CEO, Director |
Retention Restricted Stock Units |
22,000 |
|
|
25 Oct 2024 |
Direct |
| Longboard Pharmaceuticals, Inc. |
President and CEO, Director |
Employee Stock Option (right to buy) |
0 |
|
|
02 Dec 2024 |
Direct |
| Longboard Pharmaceuticals, Inc. |
President and CEO, Director |
Restricted Stock Unit |
0 |
|
|
02 Dec 2024 |
Direct |